PRESS RELEASE published on 04/14/2023 at 11:15, 1 year 7 months ago Viscom AG: Peter Krippner ends Executive Board activities at Viscom AG
PRESS RELEASE published on 03/30/2023 at 16:29, 1 year 7 months ago EQS-Adhoc: Viscom AG: Subsidiary Exacom GmbH receives major order from the energy storage products sector
PRESS RELEASE published on 03/28/2023 at 07:55, 1 year 7 months ago Viscom AG: Record highs for incoming orders and revenue; profitability negatively impacted by supply bottlenecks; further growth anticipated in 2023 financial year
PRESS RELEASE published on 01/23/2023 at 14:39, 1 year 9 months ago EQS-Adhoc: Viscom AG: Annual forecast for 2022 exceeded
Published on 11/22/2024 at 23:55, 10 hours 40 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 11 hours 5 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 11 hours 30 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 12 hours 5 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 16 hours 20 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 16 hours 41 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 17 hours 39 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 18 hours 35 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 3 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 15 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 16 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 16 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
